JPWO2020234274A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020234274A5
JPWO2020234274A5 JP2021563212A JP2021563212A JPWO2020234274A5 JP WO2020234274 A5 JPWO2020234274 A5 JP WO2020234274A5 JP 2021563212 A JP2021563212 A JP 2021563212A JP 2021563212 A JP2021563212 A JP 2021563212A JP WO2020234274 A5 JPWO2020234274 A5 JP WO2020234274A5
Authority
JP
Japan
Prior art keywords
oxy
propyl
quinolin
pyran
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021563212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533913A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/063914 external-priority patent/WO2020234274A1/en
Publication of JP2022533913A publication Critical patent/JP2022533913A/ja
Publication of JPWO2020234274A5 publication Critical patent/JPWO2020234274A5/ja
Pending legal-status Critical Current

Links

JP2021563212A 2019-05-21 2020-05-19 パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ Pending JP2022533913A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201900608 2019-05-21
DKPA201900608 2019-05-21
PCT/EP2020/063914 WO2020234274A1 (en) 2019-05-21 2020-05-19 New catecholamine prodrugs for use in the treatment of parkinson's disease

Publications (2)

Publication Number Publication Date
JP2022533913A JP2022533913A (ja) 2022-07-27
JPWO2020234274A5 true JPWO2020234274A5 (ru) 2023-05-18

Family

ID=70857151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563212A Pending JP2022533913A (ja) 2019-05-21 2020-05-19 パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ

Country Status (5)

Country Link
US (1) US20220213071A1 (ru)
EP (1) EP3972970A1 (ru)
JP (1) JP2022533913A (ru)
CN (1) CN113727979A (ru)
WO (1) WO2020234274A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729710B2 (en) 2017-11-24 2020-08-04 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's disease
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
CN116568672A (zh) 2020-11-17 2023-08-08 H.隆德贝克有限公司 用于治疗帕金森病的新儿茶酚胺前药
WO2023208865A1 (en) 2022-04-25 2023-11-02 Integrative Research Laboratories Sweden Ab NOVEL 1,2,3,4,4a,5,6,7,8,9,10,10a-DODECAHYDROBENZO[G]QUINOLIN-6-OL COMPOUNDS AND USES THEREOF
WO2023208869A1 (en) 2022-04-25 2023-11-02 Integrative Research Laboratories Sweden Ab NOVEL ESTERS OF 1,2,3,4,4a,5,6,7,8,9,10,10a-DODECAHYDROBENZO[G]QUINOLIN-6-OL COMPOUNDS AND USES THEREOF
WO2023208867A1 (en) 2022-04-25 2023-11-02 Integrative Research Laboratories Sweden Ab NOVEL 1,2,3,4,4a,5,8,9,10,10a-DECAHYDROBENZO[G]QUINOLIN-6(7H)-ONE COMPOUNDS AND USES THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543256A (en) 1982-03-17 1985-09-24 Northeastern University (-)-10,1L Methylenedioxy-N-N-propylnoraporphine and methods employing it for inhibiting the effects of epileptic seizures and for prevention and treatment of duodenal ulcers
SE0001438D0 (sv) 2000-04-18 2000-04-18 Axon Chemicals Bv New chemical compounds and their use in therapy
SE0102036D0 (sv) 2001-06-08 2001-06-08 Axon Biochemicals Bv Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
US7101912B2 (en) 2002-12-06 2006-09-05 Xenoport, Inc. Carbidopa prodrugs and derivatives, and compositions and uses thereof
TWI404702B (zh) 2007-08-31 2013-08-11 Lundbeck & Co As H 兒茶酚胺衍生物和其前藥
US20090124651A1 (en) * 2007-08-31 2009-05-14 H. Lundbeck A/S Catecholamine derivatives and prodrugs thereof
TW201036949A (en) 2009-02-27 2010-10-16 Lundbeck & Co As H Treatment of dyskinesia related disorders
US10729710B2 (en) 2017-11-24 2020-08-04 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's disease

Similar Documents

Publication Publication Date Title
JP5992049B2 (ja) 置換されたキナゾリノンのための経口速放性製剤
JP2013545730A5 (ru)
JP2020507589A5 (ru)
JP2021500394A5 (ru)
JPWO2020234274A5 (ru)
JP2007522142A5 (ru)
JP2009536191A5 (ru)
MX2021013112A (es) Un procedimiento para la fabricacion de acido (2s,3s,4s,5r,6s)-3,4,5-trihidroxi-6-(((4ar,10ar)-7-hidroxi-1-prop il-1,2,3,4,4a,5,10,10a-octahidrobenzo[g]quinolin-6-il)oxi)tetrahi dro-2h-piran-2-carboxilico e intermedio del mismo.
JP2019535723A5 (ru)
RU2014152697A (ru) Новые производные салициловой кислоты, их фармацевтически приемлемая соль, композиции и способ применения
HRP20140326T1 (hr) Derivat aromatiäśnog 6-äślanog prstena koji sadrži dušik i farmaceutsko sredstvo koje sadrži taj derivat
JP2017503753A5 (ru)
JP2004509837A5 (ru)
RU2016149761A (ru) Производные нуклеозидов для лечения ракового заболевания
JPWO2020234276A5 (ru)
JP2006522023A5 (ru)
JP2005508381A5 (ru)
WO2008124823A1 (en) Method of treating melanoma
JP2005538974A5 (ru)
TWI580670B (zh) 作爲鱗狀癌及肝癌抑制劑的類化合物及其用途
JP2011514893A5 (ru)
JP2018536637A5 (ru)
WO2016195021A1 (ja) 水性液剤
JPWO2020234275A5 (ru)
JP2536678B2 (ja) 光学活性キノリンカルボン酸誘導体